The New Frontier of Bioethics: Challenges and Imperatives in the Era of Generative Artificial Intelligence

Abstract

The rise of Generative Artificial Intelligence (AI) represents one of the most significant technological transformations of the 21st century, with a profound and imminent impact on medicine, biomedical research, and public health. Advanced language models, generative adversarial networks, and other AI architectures are capable of creating novel and complex content, ranging from diagnostic reports and personalized treatment plans to the design of new molecules and the predictive analysis of genomic data. However, this disruptive capability introduces an unprecedented spectrum of ethical dilemmas that challenge the traditional pillars of bioethics. This analysis explores the intersection between bioethics and generative AI, examining the implications of this technology through the principles of autonomy, beneficence, non-maleficence, and justice. The complexity of informed consent is discussed, particularly when patient data are used to train algorithms, as well as the issue of accountability in cases of AI-generated diagnostic errors, the risk of exacerbating health disparities due to algorithmic bias, and unequal access to technology. In addition, the article addresses emerging concerns such as large-scale health data privacy, the integrity of scientific research, and the very nature of clinical decision-making within a human–machine partnership. It concludes that the ethical integration of generative AI in healthcare requires the development of new regulatory frameworks, robust data governance, and the continuous education of healthcare professionals, in order to ensure that technological innovation serves human well-being while respecting patients’ dignity and fundamental rights.